Now, now guys. Good discussion, lets keep it civil.
I've been comparing various medical marijuana producers based mainly on the relation between cashflow revenue and market cap, revenue and cashflow expenses, plus increases in annual revenue on a rolling basis based on the quaterelys. I've looked at CPH. IHL, LGP and EOF. Just started on ECS, so not able to be too precise, but preliminary notes show that LGP is way ahead of ECS, especially on the Revenue to MC ration - by a long shot. Also, LGP is growing revenue at a great rate; ECS is slow or maybe even going backwards - unable to confirm which yet.
- Forums
- ASX - By Stock
- LGP
- Ann: $2.5m firm order increases expected DEMECAN revenue to $5.7m
Ann: $2.5m firm order increases expected DEMECAN revenue to $5.7m, page-14
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LGP (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.002(2.02%) |
Mkt cap ! $29.27M |
Open | High | Low | Value | Volume |
9.6¢ | 9.9¢ | 9.4¢ | $16.42K | 171.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7307 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 6748 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7307 | 0.097 |
1 | 292540 | 0.095 |
1 | 107000 | 0.094 |
1 | 10880 | 0.091 |
2 | 64411 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 6748 | 1 |
0.099 | 110441 | 3 |
0.100 | 171911 | 6 |
0.105 | 96952 | 5 |
0.110 | 86430 | 5 |
Last trade - 15.59pm 05/08/2024 (20 minute delay) ? |
Featured News
LGP (ASX) Chart |